One conversation could unlock mental health care for millions with chronic disease
NCT ID NCT07116655
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a single, solution-focused talk session can help people who have both a chronic physical disease and mental health issues to engage with mental health services. Researchers will enroll 60 adults from community healthcare settings who are not currently in mental health care. The session uses a structured action plan and a 'miracle question' to help participants identify and work toward a personal goal.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Single-session solution-focused consultation (a brief talk-based therapy session)
- What this could lead to
- If it works, this could offer a quick, low-cost way to help people with both chronic physical and mental health problems start getting the mental health support they need.
- What could go wrong
- This is a very small, early feasibility study with only 60 participants. It tests a single session, so lasting effects are uncertain. Results may not apply to everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 60 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Feb 2025
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
21 to 99 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. A history of one or more chronic physical diseases based on the Ministry of Health (Singapore) Chronic Disease Management Programme guidelines; 2. A score of 5 or more on the Patient Health Questionnaire (PHQ-9) or Generalized Anxiety Disorder-7 (GAD-7); 3. Not currently engaged in formal mental health service; 4. Conversant in the English language; 5. Receiving treatment in a community healthcare setting Exclusion Criteria: 1. A history of psychosis, intellectual disability, or pervasive developmental disorders
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Treatment engagement are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The study's own enquiry address
This study publishes an address for enquiries. See it below .
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Renal Health Services
RECRUITINGSingapore, Singapore
Contact Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.